Improving cancer immunotherapy by targeting tumor-induced immune suppression

By Stewart Trina  

Cancer and Metastasis Reviews, Vol. 30, Iss. 1, 2011-03 ,pp. : 125-140

Springer Publishing Company

Access to resources Recommend Favorite

Mechanisms of immune privilege for tumor cells by regulatory cytokines produced by innate and acquired immune cells

By Seo N.   Hayakawa S.   Tokura Y.  

Seminars in Cancer Biology, Vol. 12, Iss. 4, 2002-08 ,pp. : 291-300

Academic Press

Access to resources Recommend Favorite

Simulation of tumor-induced angiogenesis and its response to anti-angiogenic drug treatment: mode of drug delivery and clearance rate dependencies

By Tee Daniel   DiStefano III Joseph  

Journal of Cancer Research and Clinical Oncology, Vol. 130, Iss. 1, 2004-01 ,pp. : 15-24

Springer Publishing Company

Access to resources Recommend Favorite

Interferon regulatory factor 8 mediates tumor-induced inhibition of antigen processing and presentation by dendritic cells

By Tourkova Irina   Shurin Galina   Ferrone Soldano   Shurin Michael  

Cancer Immunology, Immunotherapy, Vol. 58, Iss. 4, 2009-04 ,pp. : 567-574

Springer Publishing Company

Access to resources Recommend Favorite

Suppression of FasL expression in tumor cells and preventing TNF-induced apoptosis was better for immune cells survival

By Xu Gaosi  

Journal of Cancer Research and Clinical Oncology, Vol. 134, Iss. 10, 2008-10 ,pp. : 1043-1049

Springer Publishing Company

Access to resources Recommend Favorite